JF
ALNY icon

Jump Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History

Jump Financial’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Sell
4,470
-14,682
-77% -$4.43M 0.01% 1054
2026
Q1 		$6.34M Sell
19,152
-11,410
-37% -$3.88M 0.08% 283
2025
Q4 		$12.2M Sell
30,562
-4,315
-12% -$1.91M 0.15% 163
2025
Q3 		$15.9M Buy
34,877
+17,485
+101% +$7.12M 0.19% 130
2025
Q2 		$5.67M Buy
17,392
+1,675
+11% +$463K 0.06% 377
2025
Q1 		$4.24M Buy
15,717
+572
+4% +$147K 0.06% 372
2024
Q4 		$3.56M Buy
+15,145
New +$3.98M 0.07% 349
2024
Q2 		– Sell
-17,554
Closed -$2.62M – 1769
2024
Q1 		$2.62M Buy
17,554
+10,262
+141% +$1.71M 0.07% 342
2023
Q4 		$1.4M Buy
+7,292
New +$1.24M 0.04% 541
2023
Q3 		– Sell
-8,439
Closed -$1.6M – 1811
2023
Q2 		$1.6M Sell
8,439
-21,337
-72% -$4.23M 0.06% 466
2023
Q1 		$5.96M Buy
29,776
+23,748
+394% +$4.99M 0.24% 114
2022
Q4 		$1.43M Buy
6,028
+4,704
+355% +$1M 0.08% 348
2022
Q3 		$265K Buy
+1,324
New +$253K 0.01% 1210

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jump Financial's ALNY Position: Q2 2026 in Review

Jump Financial reduced its Alnylam Pharmaceuticals (ALNY) stake by 77% in Q2 2026, selling an estimated $4.43M and leaving 4,470 shares worth $1.35M. The position accounts for 0.01% of the portfolio, ranked #1054.

Jump Financial first reported a position in ALNY in Q3 2022 and has held it in 13 quarters since. The position peaked at $15.9M in Q3 2025. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Jump Financial held 4,470 shares of Alnylam Pharmaceuticals worth $1.35M as of Q2 2026.
  • Jump Financial sold 14,682 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $4.43M.
  • Alnylam Pharmaceuticals made up 0.01% of Jump Financial's portfolio in Q2 2026, its #1054 holding.
  • Jump Financial first reported a position in Alnylam Pharmaceuticals in Q3 2022 and has held it in 13 quarters since.
  • Jump Financial's Alnylam Pharmaceuticals position peaked at $15.9M in Q3 2025.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.